Kyto Technology and Life Science, Inc.
Other OTCTotal Valuation
Kyto Technology and Life Science, Inc. carries a market capitalization of 13.29M, placing it among publicly traded companies globally. Its enterprise value stands at 26.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.29M |
| Enterprise Value | 26.07M |
Share Statistics
Kyto Technology and Life Science, Inc. currently has 13.29M shares outstanding.
| Shares Outstanding | 13.29M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Kyto Technology and Life Science, Inc. trades at a trailing price-to-earnings ratio of 26.49. The price-to-sales ratio is -52,578.86, and the price-to-book ratio stands at -0.83.
| PE Ratio | 26.49 |
| PS Ratio | -52,578.86 |
| PB Ratio | -0.83 |
| P/TBV Ratio | 2.08 |
| P/FCF Ratio | -10.39 |
| P/OCF Ratio | -6.45 |
Financial Position
Kyto Technology and Life Science, Inc. maintains a current ratio of 6.15, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.15 |
| Quick Ratio | 4.15 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -809.03 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 11.61 |
| Return on Invested Capital (ROIC) | -13.37 |
| Return on Capital Employed (ROCE) | -3.51 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Kyto Technology and Life Science, Inc.'s stock has declined approximately -50% over the past 52 weeks. The 50-day moving average sits at 1.00, while the 200-day moving average is 1.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Kyto Technology and Life Science, Inc. generated -505.00 in revenue and converted that into 1.13M in net income, yielding earnings per share of 0.05. EBITDA reached -1.29M, while operating income came in at -1.29M.
| Revenue | -505.00 |
| Gross Profit | N/A |
| Operating Income | -1.29M |
| Pretax Income | 1.13M |
| Net Income | 1.13M |
| EBITDA | -1.29M |
| EBIT | -1.29M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
Total book value stands at -31.84M, with working capital of 755,112.00 providing operational flexibility.
| Cash & Cash Equivalents | 608,223.00 |
| Total Debt | N/A |
| Net Debt | -608,223.00 |
| Equity (Book Value) | -31.84M |
| Book Value Per Share | -2.40 |
| Working Capital | 755,112.00 |
Cash Flow
Kyto Technology and Life Science, Inc. produced -4.11M in operating cash flow over the past twelve months.
| Operating Cash Flow | -4.11M |
| Capital Expenditures | N/A |
| Free Cash Flow | -4.11M |
| FCF Per Share | -0.31 |
Margins
Kyto Technology and Life Science, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 255,685.54 and net profit margin of -224,614.85 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 255,685.54 |
| Pretax Margin | -224,614.85 |
| Profit Margin | -224,614.85 |
| EBITDA Margin | 255,685.54 |
Dividends & Yields
The company's payout ratio of -13.17 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | -13.17 |
| Shareholder Yield | -15.66 |
| FCF Yield | -9.62 |
Stock Splits
Kyto Technology and Life Science, Inc.'s most recent stock split took place on November 4, 2015 with a 10:1 split ratio.
| Last Split Date | 11/4/2015 |
| Split Ratio | 10:1 |
Scores
Kyto Technology and Life Science, Inc. posts an Altman Z-Score of 104.93, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 104.93 |